The biotechnology sector has been on fire this year as investors bank on big returns from the development of new drugs and medical sciences. The First Trust NYSE Arca Biotechnlgy Indx Fd (NYSE: FBT) leads this group with a total return of nearly 50 percent in 2014.
While there are numerous choices for playing the biotechnology theme using ETFs, a new fund sponsor is offering a unique opportunity to hone in on two specific niches.
On Wednesday, LifeSci Index Partners, LLC launched the BioShares Biotechnology Clinical Trials Fund (NASDAQ: BBC) and the BioShares Biotechnology Products Fund (NASDAQ: BBP). Both funds are available on the ...
/www.benzinga.com/trading-ideas/long-ideas/14/12/5088375/2-new-biotech-etfs-offer-unique-industry-focus alt=2 New Biotech ETFs Offer Unique Industry Focus>Full story available on Benzinga.com
More...